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1341 
EFFECTIVENESS OF FEDERAL REGULATION 
OF MOBILE MEDICAL APPLICATIONS 
INTRODUCTION 
Steve Jobs hated the design of the health-monitoring devices used to 
treat him during his final days.
1
 In posthumous homage to its founder, 
Apple released the Health app, powered by the HealthKit developer 
framework, as part of its iOS 8 operating system update and its new 
iPhone 6 release in September of 2014.
2
 HealthKit allows the Health app 
to access third party apps and wearable devices.
3 Although the Health 
app—as a mobile medical application (“app”)—could arguably fit the 
mold of a medical device subject to Food and Drug Administration 
(“FDA”) regulation, Apple managed to escape such regulation of its 
product. This Note discusses the reasons this occurred.
4
  
A myriad of medical smartphone apps are available in the app market.
5
 
Apple’s foray into the market triggered a surge in apps that are compatible 
with the Health app.
6
 As a result, mobile health applications are becoming 
more integrated into Americans’ everyday lives. 
Samsung, a fierce competitor in the smartphone market, is also touting 
the health and wellness features of its Galaxy S5.
7
 The Galaxy S5 is the 
 
 
 1.  Brian X. Chen, Success of Apple’s iWatch May Rely on Health Care Partnerships, N.Y. 
TIMES (Sept. 7, 2014), http://www.nytimes.com/2014/09/08/technology/can-apple-build-a-cool-and-
convenient-iwatch.html. 
 2. HealthKit, now known as the Health app, was slightly delayed and was not released 
concurrently with iOS 8. Lauren Goode, Bug Delays Launch of Apps Using Apple’s HealthKit in iOS 
8, RECODE (Sept. 17, 2014, 4:10 PM), http://recode.net/2014/09/17/bug-delays-launch-of-apps-using-
apples-healthkit-in-ios-8/. “The health dashboard app is getting an update in iOS 9.3 that adds 
sliders to categories like weight, workout or sleep that provide suggestions for apps that may help you 
reach your goals in these areas. It also integrates your move, exercise and stand data from the Apple 
watch to simplify your health data tracking to one app.” Cammy Harbison, iOS 9.3 Preview: Apple to 
Bring Multi-User iPad, Lock for Apps, Night Mode and More, IDIGITALTIMES (Jan. 11, 2016, 2:32 
PM), http://www.idigitaltimes.com/ios-93-preview-apple-bring-multi-user-ipad-lock-apps-night-mode 
-and-more-503097. 
 3. HealthKit, APPLE INC., https://developer.apple.com/healthkit/ (last visited Apr. 8, 2016). 
 4. Brian Dolan, FDA Makes Clear It Won’t Regulate Apps Like Apple’s HealthKit, 
MOBIHEALTHNEWS.COM (June 16, 2014), http://mobihealthnews.com/34173/fda-makes-clear-it-wont-
regulate-apps-like-apples-healthkit/. 
 5. “More than 100,000 health apps are available in the iTunes and Google Play stores . . . .” 
Joshua A. Krisch, Questioning the Value of Health Apps, N.Y. TIMES (Mar. 16, 2015, 3:27 PM), 
http://well.blogs.nytimes.com/2015/03/16/health-apps-provide-pictures-if-not-proof-of-health/?_r=0. 
 6. Aditi Pai, 23 Health and Wellness Apps That Connect to Apple’s HealthKit, 
MOBIHEALTHNEWS.COM (Sept. 30, 2014), http://mobihealthnews.com/36870/23-health-and-wellness-
apps-that-connect-to-apples-healthkit/. 
 7. Samsung Galaxy S5: Features, SAMSUNG, http://www.samsung.com/global/microsite/ 
galaxys5/features.html (last visited Apr. 8, 2016). 
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first smartphone with a built-in heart rate monitor.
8
 Samsung included 
SHealth software, similar to Apple’s Health app, which is compatible with 
the Galaxy S5 pedometer.
9
 The Galaxy S5 also connects to Samsung Gear 
Fit, a wristband that provides personalized real-time information on the 
progress and results of a workout using the device’s optical heart rate 
sensor, similar to the Apple Watch.
10
  
These are just two examples of how mobile health is expanding from 
basic pedometers and informative medical apps into more complex 
interactive programs and apps. It is understandable that governmental 
regulation has not been able to adequately keep pace with mobile medical 
technology.
11
 The rapidly growing popularity of smartphones in the 
consumer market has triggered aggressive investment in mobile health, 
sometimes referred to as “mHealth.”12 Some of the mHealth investment 
money goes toward the development of medical apps.
13
 Technology 
companies are rolling out sophisticated applications for computers and 
smartphones that can perform a wide variety of tasks; from basic 
monitoring of personal health statistics to complex medical testing and 
diagnosis, including a pregnancy test app that utilizes a smart phone’s 
Bluetooth,
14
 an app that monitors blood pressure,
15
 and even an app that 
can conduct a urinary analysis.
16
  
 
 
 8. Bahar Gholipour, Galaxy S5: How the Heart-Rate Monitor Compares to Other Devices, LIVE 
SCIENCE (May 8, 2014, 1:35 PM), http://www.livescience.com/45458-galaxy-s5-heart-rate-
comparison-experiment.html. When compared to heart rate apps found in the Google Play store, the 
margin of error between Samsung and the apps was negligible, so it is not clear that the Galaxy S5 
heart rate monitor is any more effective than the free and inexpensive apps found in the iTunes store or 
the Google Play store that are compatible with phones without a built in monitor. Daniel P., Cool 
Gimmicks: Galaxy S5 Heart Rate Sensor vs a Pulse Measuring App, PHONE ARENA (Apr. 11, 2014, 
8:43 PM), http://www.phonearena.com/news/Cool-gimmicks-Galaxy-S5-heart-rate-sensor-vs-a-pulse-
measuring-app_id55037. 
 9. See Samsung Galaxy S5: Features, supra note 7. 
 10. Samsung Gear: Features, SAMSUNG, http://www.samsung.com/global/microsite/gear/ 
gearfit_features.html (last visited Apr. 8, 2016). 
 11. Mobile medical health is a fairly new area of regulatory law, as smartphones and apps for 
smartphones did not even exist before 2007. The FDA May Want to Regulate Your mHealth App.—
Updated, OMNICA CORP. (Sept. 23, 2014), http://www.omnica.com/the-fda-will-look-at-your-mhealth-
app/. 
 12. “‘Mobile health,’ or ‘mHealth,’ is the use of mobile communications devices like 
smartphones and tablet computers for health or medical purposes, usually for diagnosis, treatment, or 
simply well-being and maintenance.” Nathan Cortez, The Mobile Health Revolution?, 47 U.C. DAVIS 
L. REV. 1173, 1176 (2014). 
 13. “CompuGroup Medical AG (CGM), a leading provider for eHealthsolutions worldwide, and 
Microsoft entered into strategic cooperation. In a mutual action plan, both Microsoft and CGM are 
investing in mobile services for better communication between doctors and patients based on CGM 
LIFE eSERVICES and Windows 8.1. Through this cooperation, CGM will strengthen its portfolio of 
mobile healthcare solutions for patients and doctors thus expanding its global technology leadership in 
the healthcare industry.” Press Release, CompuGroup Medical AG, CompuGroup Medical AG and 
Microsoft Focus on Mobile Applications in Healthcare Together (Mar. 28, 2014).  
 14. Megan Friedman, An iPhone App Can Now Tell You If You’re Pregnant, ELLE (Jan. 6, 2016), 
http://www.elle.com/life-love/sex-relationships/news/a33051/first-response-bluetooth-pregnancy-test/. 
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Due to the rapid growth and advancement of technology, uncertainty 
has emerged as to whether some of the medical apps on the market should 
be considered medical devices, which are subject to stringent regulation by 
the FDA.
17
 The FDA issued final guidelines regarding the regulation of 
medical apps in September of 2013 and updated the guidance in February 
2015, but it has not issued formal regulations.
18
  
Mobile technology is an integral part of daily life in the United States; 
as of January 2014, 90% of adults in the United States owned a cell phone, 
and 64% of adults owned a smartphone.
19
 Almost 20% of smartphone 
users in the United States have at least one application on their device that 
helps them track or manage their health and have used such an app in the 
past year.
20
 By some estimates, 500 million users worldwide will use one 
or more of these apps within the year.
21
 And by 2018, more than 50% of 
the 3.4 billion smartphone and tablet users worldwide will have 
downloaded a medical health app.
22
  
Relevant to this Note, smartphones and medical apps are becoming 
increasingly popular among healthcare professionals. Nearly eighty 
percent of physicians use smartphones as part of their medical practice.
23
 
 
 
 15. Maxwell Software, Blood Pressure Companion, ITUNES (May 9, 2016), https://itunes.apple. 
com/us/app/blood-pressure-companion/id453210774?mt=8. 
 16. Anna Edney, iPhone Urinalysis Draws First FDA Inquiry of Medical Apps, BLOOMBERG 
TECH. (May 23, 2013), http://www.bloomberg.com/news/2013-05-23/iphone-urinalysis-draws-first-
fda-inquiry-of-medical-apps.html. 
 17. Stephanie Kreml, FDA Creates Medical App Regulation Maze, INFO. WK. (Mar. 3, 2014, 
3:24 PM), http://www.informationweek.com/healthcare/mobile-and-wireless/fda-creates-medical-app-
regulation-maze/d/d-id/1114095 (“[T]he [2013 FDA] guidance also showed the agency’s uncertainty 
over how the world of medical apps is going to evolve.”). 
 18. FOOD AND DRUG ADMIN., U.S. DEP’T OF HEALTH & HUMAN SERVS., MOBILE MEDICAL 
APPLICATIONS: GUIDANCE FOR INDUSTRY AND FOOD AND DRUG ADMINISTRATION STAFF (2015), 
available at http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/Guidance 
Documents/UCM263366.pdf. 
 19. Mobile Technology Fact Sheet, PEW RESEARCH CTR., http://www.pewinternet.org/fact-shee 
ts/mobile-technology-fact-sheet/ (last visited Apr. 8, 2016).  
 20. Health Fact Sheet, PEW RESEARCH CTR., http://www.pewinternet.org/fact-sheets/health-fact-
sheet/ (last visited Apr. 8, 2016).  
 21. Honor Whiteman, Health Apps: Do They Do More Harm Than Good?, MED. NEWS TODAY 
(Sept. 26, 2014), http://www.medicalnewstoday.com/articles/283117.php. Due to the tremendous 
popularity of smartphones and apps, it is no surprise that the mobile app market is a booming industry. 
“[M]obile apps are projected to be a $25 billion industry this year [2013] and are estimated to have 
already produced 500,000 jobs.” Health Information Technologies: Harnessing Wireless Innovation, 
Memorandum of Hearing Before Subcomm. on Commc’ns. and Tech., 113th Cong. 1 (2013).  
 22. RESEARCH2GUIDANCE, MOBILE HEALTH MARKET REPORT 2013–2017: THE 
COMMERCIALIZATION OF MHEALTH APPLICATIONS (VOL. 3) 7 (2013), available at http://research2 
guidance.com/wp-content/uploads/2015/08/Mobile-Health-Market-Report-2013-2017-Preview.pdf. 
 23. According to a 2013 survey, “[n]early 80 percent of the 300 practicing primary care, family 
and internal medicine physicians surveyed said they were using a smartphone in their day-to-day 
practice. Another 61% were using tablets.” Stephen Beck, Mobile Health Is Enhancing Clinical 
Decisions at the Point of Care, HIT CONSULTANT (June 9, 2014), http://hitconsultant.net/2014/ 
06/09/mobile-health-is-enhancing-clinical-decisions-at-the-point-of-care/.  
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And eighty-five percent of physicians use medical applications as part of 
their practice.
24
  
This Note proceeds as follows. Part I examines the development of 
mobile medical health applications and regulation in countries with 
comparable mobile-app use, and then explores the evolution of the FDA’s 
position regarding the regulation of such apps. Part II analyzes and 
critiques current and conceivable regulatory strategies by the federal 
government, as well as private regulatory organizations such as the United 
States Pharmacopeial Convention and the Health on the Net Foundation. 
Part III argues that current FDA regulations are insufficient and suggests a 
peer reviewer or other organization may be better suited to assess the 
usability of apps and offer usage guidelines for consumers. Part III also 
discusses three proposed models for regulation of mobile medical apps. 
This Note argues that a regulatory approach that includes a peer review 
system and a non-profit organization that specializes in mobile medical 
technology will be more efficient and useful to monitor mobile medical 
apps than the current FDA guidelines.  
I. HISTORY  
A. Medical Apps 
Health and medical apps first emerged in the late 2000s by offering 
tools such as calorie counters and simple wearable devices like pedometers 
that were integrated with cell phone apps.
25
 Medical apps have 
consistently grown in popularity, and large technology companies 
continue to invest in mobile health.
26
  
Mobile medical apps often utilize a smartphone’s built-in features, like 
touch screens, cameras, lights, sounds, and wireless access, as well as 
software to process the data collected.
27
 The information gathered can be 
presented to the user in an informative or even in a diagnosis-like format. 
Increasingly accessible and more affordable technology has allowed more 
people to access such applications but has also raised questions and 
concerns regarding safety and regulation. 
 
 
 24. “In addition, 86 percent of all clinicians—doctors, nurses and nurse practitioners—now use 
smartphones in their practice areas every day, up from 78 percent in 2012.” Id. As doctors have 
superior medical knowledge and experience to determine if an app is reliable enough to use in their 
practice and treatment of patients, this Note focuses on consumer use of medical apps. However, 
doctors could also benefit from a greater level of peer review and more information on the efficacy and 
safety of mobile medical health apps. 
 25. HEALTHAFFAIRS & ROBERT WOOD JOHNSON FOUND., HEALTH POLICY BRIEF: MHEALTH 
AND FDA GUIDANCE, at 2 (2013). 
 26. Press Release, CompuGroup Medical AG, supra note 13.  
 27. Cortez, supra note 12, at 1177. 
https://openscholarship.wustl.edu/law_lawreview/vol93/iss5/8
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Some companies have developed devices that work in tandem with 
smartphones but do not require a mobile phone to operate.
28
 For example, 
Scanadu, a Silicon Valley-based company that makes medical technology 
devices for consumers, created a device that can monitor and log the data 
of pulse, respiratory rate, blood pressure, temperature, and other 
vitals.
29
 Because it is a standalone device, the FDA required Scanadu to 
seek further approval before the device goes onto the market.
30
  
Like standalone health devices, mobile phones can be used to engage in 
complex medical procedures through applications that work in conjunction 
with smartphone features and external tools and devices that plug into 
smartphones. Such features and programs on mobile phones may also be 
subject to the same discretionary review and regulation by the FDA as 
standalone devices. External devices that attach to the phone are 
particularly easy to peg for further review and approval, particularly if the 
application gives diagnostic-like data readings.  
One such app that offers the user a diagnosis is the Instant Heart Rate 
app.
31
 The application can take the user’s heart rate by allowing the user to 
place his or her finger over the camera for ten seconds.
32
 Another app that 
utilizes a smartphone’s built in features is BiliCam, which allows parents 
to check if their newborn has jaundice by taking a picture of a calibration 
card against their baby’s skin.33  
Due to time and monetary constraints, mobile app developers do not 
want their apps to be subject to FDA and regulatory scrutiny. Whether a 
mobile app is a medical device is not as clear-cut as it is for a stand-alone 
medical device that is clearly designed for the purpose of diagnosis or 
treatment. Policy and regulation have yet to catch up with this evolving 
technology, creating a gray area encompassing such mobile health apps.   
 
 
 28. See, e.g., SCANADU, http://www.scanadu.com (last visited Apr. 8, 2016). 
 29. Stacey Higginbotham, The Scanadu Scout’s Big Breakthrough May Actually Be in Clinical 
Trials, GIGAOM (May 24, 2013, 10:49 AM), https://gigaom.com/2013/05/24/the-scanadu-scouts-big-
breakthrough-may-actually-be-in-in-clinical-trials/.  
 30. Cortez, supra note 12, at 1176. 
 31. Azumio Inc., Instant Heart Rate—Heart Rate Monitor & Fitness Buddy Training Tracker 
Programs, ITUNES, https://itunes.apple.com/us/app/instant-heart-rate-heart-rate/id395042892?mt=8 
(last visited July 8, 2016). 
 32. Alex Krouse, iPads, iPhones, Androids, and Smartphones: FDA Regulation of Mobile Phone 
Applications as Medical Devices, 9 IND. HEALTH L. REV. 731, 743 (2012). 
 33. Catharine Paddock, Smartphone App to Screen for Jaundice in Newborns, MED. NEWS 
TODAY (Aug. 29, 2014), http://www.medicalnewstoday.com/articles/281701.php.  
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B. History of FDA Involvement in Mobile Medical Apps  
The FDA is a federal agency that exists under the purview of the US 
Department of Health and Human Services.
34
 The FDA is responsible for 
protecting and promoting public health through the regulation and 
supervision of food safety, over-the-counter and prescription drugs, 
dietary supplements, and other food and medical products and devices 
available to consumers.
35
 Pertinent to this Note, the FDA is empowered by 
Congress to enforce the Federal Food, Drug and Cosmetic Act, among 
other laws.
36
 Notably, the FDA enforces section 361 of the Public Health 
Service Act and associated regulations, from which it derives its authority 
to regulate medical devices.
37
 More specific statutory authority is exerted 
“over those mobile apps that meet the definition of ‘device’ in section 
201(h) of the Federal Food, Drug, and Cosmetic Act (FD&C Act).”
38
 
The FDA issued its first guidance regarding mobile medical 
applications in July of 2011, after soliciting public and stakeholder 
comments and opinions.
39
 Those that responded “overwhelmingly 
supported a narrowly tailored, risk-based approach.”
40
 Industry 
stakeholders were eager for guidance from the FDA so they could proceed 
with research and development.
41
 The FDA released this guidance in its 
report, Mobile Medical Applications: Guidance for Industry and Food and 
Drug Administration Staff, in the Federal Register in September of 2013.
42
  
In the 2013 Guidance, the FDA attempted to define what factors make 
a mobile app a medical device, stating: 
Mobile apps that transform a mobile platform into a regulated 
medical device and therefore are mobile medical apps: These 
 
 
 34. U.S. FOOD & DRUG ADMIN., http://www.fda.gov (last visited Apr. 8, 2016). 
 35. FDA Organization, U.S. FOOD & DRUG ADMIN., http://www.fda.gov/AboutFDA/ 
CentersOffices/default.htm (last visited Apr. 8, 2016). 
 36. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq. (2014). 
 37. Public Health Service Act, 42 U.S.C. § 361 (2014).  
 38. Examining Federal Regulation of Mobile Medical Apps and Other Health Software: Hearing 
Before the Subcomm. on Health of the H. Comm. on Energy and Commerce, 113th Cong. (2013) 
(statement of Jeffrey Shuren, Dir., Ctr. for Devices & Radiological Health, Food & Drug Admin.), 
available at http://www.fda.gov/NewsEvents/Testimony/ucm375462.htm [hereinafter Hearing on 
Mobile Medical Apps]; see also Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 321(h). 
 39. Press Release, U.S. Food & Drug Admin., FDA Outlines Oversight of Mobile Medical 
Applications (July 19, 2011). 
 40. Hearing on Mobile Medical Apps, supra note 38; see also Public Workshop - Mobile Medical 
Applications Draft Guidance, September 12-13, 2011, U.S. FOOD & DRUG ADMIN., http://www.fda. 
gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm267821.htm (last visited Apr. 8, 2016). 
 41. See Public Workshop—Mobile Medical Applications Draft Guidance, supra note 4.  
 42. Hearing on Mobile Medical Apps, supra note 38; see also Mobile Medical Applications; 
Guidance for Industry and Food and Drug Administration Staff; Availability, 78 Fed. Reg. 59,038 
(Sept. 25, 2013). 
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2016] REGULATION OF MOBILE MEDICAL APPLICATIONS 1347 
 
 
mobile apps use a mobile platform’s built-in features such as light, 
vibrations, camera, or other similar sources to perform medical 
device functions (e.g., mobile medical apps that are used by a 
licensed practitioner to diagnose or treat a disease).
43
  
The FDA distinguished some types of apps they will regulate from some 
they will not. However, the Guidance leaves a considerable amount of 
discretion to the FDA.
44
 FDA director Jeffery Shuren explained the FDA’s 
stance on medical app regulation in a hearing before the Subcommittee on 
Health of the House Committee on Energy and Commerce, stating: 
Our mobile medical app policy is based on risk and functionality. 
For example, an electrocardiography device—an ECG machine—
that measures heart rhythms to help doctors diagnose patients is still 
an ECG machine, regardless of whether it is the size of a bread box 
or the size of a credit card. The risks it poses to patients and the 
importance of ensuring for practitioners and patients that it is safe 
and effective are essentially the same. Our guidance makes clear 
that if a mobile app transforms a mobile platform into a medical 
device, like an ECG machine, or is an accessory to a medical 
device, such as an app that acts as a remote control for a CT 
scanner, and it is the kind of functionality we already regulate—that 
is, we have approved, cleared, or classified such a device—we 
would continue to regulate that kind of technology, if it is on a 
mobile platform.
45
 
The FDA considers a mobile health app to be a medical device if the app 
meets the definition of a medical device, is an accessory to a regulated 
medical device, or transforms a mobile platform into a regulated medical 
device.
46
 The FDA determines whether an app is a device by evaluating 
 
 
 43. Examples of MMAs the FDA Regulates, U.S. FOOD & DRUG ADMIN., http://www.fda.gov/ 
medicaldevices/digitalhealth/mobilemedicalapplications/ucm368743.htm (last visited Apr. 8, 2016).  
 44. See Examples of Pre-Market Submissions That Include MMAs Cleared or Approved by FDA, 
U.S. FOOD & DRUG ADMIN., http://www.fda.gov/MedicalDevices/DigitalHealth/MobileMedical 
Applications/ucm368784.htm (last visited Apr. 8, 2016); see also Examples of MMAs That Are NOT 
Medical Devices, U.S. FOOD & DRUG ADMIN., http://www.fda.gov/MedicalDevices/DigitalHealth/ 
MobileMedicalApplications/ucm388746.htm (last visited Apr. 8, 2016); Examples of Mobile Apps for 
Which the FDA Will Exercise Enforcement Discretion, U.S. FOOD & DRUG ADMIN., 
http://www.fda.gov/MedicalDevices/DigitalHealth/MobileMedicalApplications/ucm368744.htm (last 
visited Apr. 8, 2016).  
 45. Hearing on Mobile Medical Apps, supra note 38. 
 46. FOOD AND DRUG ADMIN., supra note 18. The definition of a medical device under the 
Federal Food, Drug, and Cosmetic Act is: 
[A]n instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or 
other similar or related article, including a component part, or accessory, which is: recognized 
in the official National Formulary, or the United States Pharmacopoeia, or any supplement to 
them; intended for use in the diagnosis of disease or other conditions, or in the cure, 
Washington University Open Scholarship
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the marketing claims of the apps.
47
 Through this guidance, the FDA 
sought “to strike the right balance by providing a risk-based, focused 
approach to the oversight of a small subset of mobile apps that present 
risks to patients if they do not work as intended.”48  
Although it seems that the FDA established guidelines, a closer 
examination reveals ambiguities in the FDA guidelines, contributing to 
uncertainty among app developers and technology companies. One 
industry concern is the scope of the regulation and the level of scrutiny 
their apps will be subject to if they fall within the FDA’s discretion.49 In 
August of 2014, the FDA released draft guidance that made many low-risk 
medical devices exempt from premarket 510(k) review, which was 
updated in February of 2015.
50
 A 510(k) is submitted to the FDA before a 
manufacturer proposes to market a medical device.
51
 If the FDA finds the 
new device is substantially equivalent to a legally marketed device, the 
manufacturer may market it immediately.
52
 The 510(k) exemption includes 
certain mobile applications that can convert a cell phone into a medical 
device.
53
 This exemption “may smooth the path to market for many 
medical mobile apps the FDA’s 2013 guidance suggested would be 
subject to premarket approval requirements.”54 
If the FDA finds an app it believes should be characterized as a 
medical device, they will alert the company through an “it has come to our 
attention” letter.55 There are several user fees associated with certain 
 
 
mitigation, treatment, or prevention of disease, in man or other animals; or, intended to affect 
the structure or any function of the body of man or other animals, and which does not achieve 
its primary intended purposes through chemical action within or on the body of man or other 
animals and which is not dependent upon being metabolized for the achievement of its 
primary intended purposes.  
Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 321(h) (2014). 
 47. See Mobile Medical Applications, U.S. FOOD & DRUG ADMIN., http://www.fda.gov/ 
MedicalDevices/DigitalHealth/MobileMedicalApplications/default.htm (last visited Apr. 8, 2016).  
 48. Hearing on Mobile Medical Apps, supra note 38. 
 49. Erin Gilmer, Developing Mobile Apps as Medical Devices: Understanding U.S. Government 
Regulations, IBM DEVELOPERWORKS (Apr. 16, 2013), http://www.ibm.com/developerworks/library/ 
mo-fda-med-devices/mo-fda-med-devices-pdf.pdf. 
 50. FOOD AND DRUG ADMIN., supra note 18, at 16. 
 51. FOOD AND DRUG ADMIN., U.S. DEP’T OF HEALTH AND HUMAN SERVS., THE 510(K) 
PROGRAM: EVALUATING SUBSTANTIAL EQUIVALENCE IN PREMARKET NOTIFICATIONS [510(K)], at 3 
(2014), available at http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ 
GuidanceDocuments/UCM284443.pdf. 
 52. This is only true for similar devices that do not require pre-market notification. Id.  
 53. Erica J. Kraus & Kristi V. Kung, New FDA Rules Are Boon to Medical Mobile App 
Developers, LAW360 (Aug. 7, 2014, 3:51 PM), http://www.law360.com/articles/564719/new-fda-
rules-are-boon-to-medical-mobile-app-developers, archived at https://perma.cc/FUC9-TTQH. 
 54. Id. 
 55. See, e.g., Letter from James L. Woods, Deputy Dir., Patient Safety & Prod. Quality, Office of 
In Vitro Diagnostics & Radiological Health, to Myshkin Ingawale, Biosense Technologies Private Ltd. 
(June 24, 2014).  
https://openscholarship.wustl.edu/law_lawreview/vol93/iss5/8
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medical device applications.
56
 The collection of fees from the medical 
industry to fund reviews of innovative drugs, medical devices, generic 
drugs, and biologics is authorized under Title II of the Food and Drug 
Administration Safety and Innovation Act (“FDASIA”).57 These fees can 
add up, particularly for small companies and start-ups, making it more 
difficult for some medical apps to enter the market.
58
  
C. The Draft Guidance 
Finding value in many mobile health applications, the FDA must 
balance innovation and risk. Therefore, the FDA has chosen to focus the 
majority of regulation on apps that could present the greatest risk to 
consumers when they malfunction.
59
 As such, the FDA will not regulate 
apps that “are not marketed, promoted or intended for use in the diagnosis 
of disease or other conditions, or in the cure, mitigation, treatment, or 
prevention of disease, or do not otherwise meet the definition of medical 
device.”60 
However, “[w]hen [apps] are marketed, promoted, or intended for use 
in the diagnosis of disease or other conditions, or in the cure, mitigation, 
treatment, or prevention of disease, or otherwise meet the definition of 
medical device,” the FDA may enforce the regulations with respect to 
those apps at its discretion.
61
 The FDA’s discretion in this regard is where 
the line blurs between exempt apps and apps that require FDA approval. 
FDA discretion is expanded under 21 CFR § 801.4, which allows products 
to be labeled as devices if they are labeled using language in the claim 
reserved for devices, even if the product does not seem to be a medical 
device.
62
   
 
 
 56. “For [fiscal year] 2013, the registration fee for each establishment is $2,575 US Dollars. 
There are no waivers or fee reductions for small businesses. Starting in [fiscal year] 
2013, all establishments must pay registration fees, regardless of establishment type or activities 
conducted.” FOOD AND DRUG ADMIN., U.S. DEP’T OF HEALTH & HUMAN SERVS., IMPORTANT 
INFORMATION ON THE MEDICAL DEVICE USER FEE RATES FOR FY 2013 (OCT 1, 2012 THROUGH SEPT. 
30, 2013) 1 (2012), available at http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationand 
Guidance/Overview/MDUFAIII/UCM315989.pdf [hereinafter MEDICAL DEVICE USER FEE RATES]. 
 57. Food and Drug Administration Safety and Innovation Act, Pub. L. No. 112-144, § 201 
(2012) (medical device user fee amendments of 2012). 
 58. See MEDICAL DEVICE USER FEE RATES, supra note 56. 
 59. Hearing on Mobile Medical Apps, supra note 38. 
 60. Id. at n.9. 
 61. Id. 
 62. 21 C.F.R. § 801.4 (2016). 
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D. Role of Other Government Agencies in Medical Mobile Health 
Regulation 
Section 618 of FDASIA, enacted on July 9, 2012, required the 
Secretary of HHS to prepare a report containing “a proposed strategy and 
recommendations on an appropriate, risk-based regulatory framework 
pertaining to health IT, including mobile medical applications, that 
promotes innovation, protects patient safety, and avoids regulatory 
duplication.”63 As a result, the FDA, the ONC, and the FCC established an 
“FDASIA Workgroup” under ONC’s Health Information Technology 
Policy Committee.
64
 The workgroup emphasized the importance of 
“treating functionality the same across platforms and recommended that 
FDA expedite guidance on mobile medical apps because of the critical 
importance of providing clarity as soon as possible.”65 
E. Medical Mobile Health in Peer Nations 
Although the United States does not have a concrete policy regarding 
mobile medical apps, other countries have instituted such policies, such as 
the United Kingdom (“UK”). The Medicines and Healthcare products 
Regulatory Agency (“MHRA”) is an executive agency of the Department 
of Health in the UK.
66
 In March 2014, the MHRA published guidance on 
medical device stand-alone software, including mobile medical apps.
67
 
According to the MHRA, software that has a medical purpose could be 
considered a medical device.
68
 The UK requires medical apps that have a 
“medical purpose” to contain a CE Mark.69 A CE Mark signifies that the 
 
 
 63. Hearing on Mobile Medical Apps, supra note 38 (quoting Food and Drug Administration 
Safety and Innovation Act, Pub. L. No. 112-144, § 201 (2012)). 
 64. Id. The workgroup gave its final recommendations in early September 2013, which the 
Committee adopted. Id. 
 65. Id.  
 66. MEDS. & HEALTHCARE PRODS. REGULATORY AGENCY, http://www.mhra.gov.uk (last visited 
Apr. 8, 2016).  
 67. Medical Device Stand-Alone Software (Including Apps), MEDS. & HEALTHCARE PRODS. 
REGULATORY AGENCY, http://www.mhra.gov.uk/Howweregulate/Devices/Devicesregulatorynews/ 
CON395239 (last visited Apr. 8, 2016).  
 68. A “medical device” is defined in the Medical Device Directive (“MDD”) as: 
“software intended by the manufacturer to be used for human beings for the purpose of: diagnosis, 
prevention, monitoring, treatment or alleviation of disease; diagnosis, monitoring, treatment, 
alleviation of or compensation for an injury or handicap; investigation, replacement or modification of 
the anatomy or of a physiological process; control of conception.” Guidance: Medical Device Stand-
Alone Software Including Apps, MEDS. & HEALTHCARE PRODS. REGULATORY AGENCY, 
https://www.gov.uk/government/publications/medical-devices-software-applications-apps/medical-dev 
ice-stand-alone-software-including-apps (last visited Apr. 9, 2016) [hereinafter Guidance on Medical 
Device Software].  
 69. Fiona Graham, Health Tech: When Does an App Need Regulating?, BBC (Oct. 13, 2014), 
http://www.bbc.com/news/business-29605951. The types of apps that are most likely to fall into the 
https://openscholarship.wustl.edu/law_lawreview/vol93/iss5/8
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developer has met the requirements of a conformative assessment.
70
 The 
requirements of the conformity assessment depend upon the classification 
of the device.
71
 Most mobile medical apps fall into Class I, meaning that 
manufacturers must self-declare their devices and register with the 
MHRA.
72
 Devices intended for diagnosis are generally Class IIa, which 
require the use of a notified body to assess compliance.
73
 The fees 
associated with MHRA applications and audits are comparable to FDA 
fees in the United States.
74
  
Additionally, the European Commission (“EC”) published a set of 
guidelines for the classification of medical software in January of 2012.
75
 
The guidelines are not legally binding, but it is expected that the 
guidelines will be used by Member States to create uniformity among 
directives for medical apps, software, and devices going forward.
76
  
F. History of Non-Profit Organizational Regulations 
Non-profit organizations can be an effective means to provide 
regulation and guidance. In this Subpart, I examine how the United States 
Pharmacopeia’s (“USP”) voluntary verification mechanism may provide a 
good structure for creating a similar verification program for mobile 
medical applications. I then consider how the structure of Health on the 
Net (“HON”), an international organization, may provide further guidance 
for the creation of a regulatory guidance system for mobile medical apps 
in the United States.  
 
 
category of medical devices are “[d]ecision support or decision making software that applies some 
form of automated reasoning, such as a simple calculation, a decision support algorithm or a more 
complex series of calculations, e.g. dose calculations, symptom tracking, clinicians guides.” Guidance 
on Medical Device Software, supra note 68.  
 70. Medical Devices: Conformity Assessment and the CE Mark, MEDS. & HEALTHCARE PRODS. 
REGULATORY AGENCY, https://www.gov.uk/guidance/medical-devices-conformity-assessment-and-
the-ce-mark (last visited Apr. 8, 2016). 
 71. Id. 
 72. Guidance on Medical Device Software, supra note 68. 
 73. Id. “A notified body is an organisation that has been designated by an EU member state (the 
designating authority) to assess whether manufacturers and their medical devices meet the 
requirements set out in legislation.” Guidance: Notified Bodies for Medical Devices, MEDS. & 
HEALTHCARE PRODS. REGULATORY AGENCY, https://www.gov.uk/government/publications/notified-
bodies-for-medical-devices/notified-bodies-for-medical-devices (last visited Apr. 8, 2016) [hereinafter 
Notified Bodies]. 
 74. Notified Bodies, supra note 73.  
 75. Guidance on Medical Device Software, supra note 68. 
 76. DIRECTORATE B, UNIT B2 “HEALTH TECHNOLOGY AND COSMETICS,” EUROPEAN COMM’N, 
GUIDELINES ON THE QUALIFICATION AND CLASSIFICATION OF STAND ALONE SOFTWARE USED IN 
HEALTHCARE WITHIN THE REGULATORY FRAMEWORK OF MEDICAL DEVICES (2012). 
Washington University Open Scholarship
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1. United States Pharmacopeia  
USP was founded in 1820, and USP standards were officially 
recognized through the Federal Food and Drug Act of 1906.
77
 USP 
develops and publishes standards for drug substances, drug products, 
excipients, and dietary supplements in the United States Pharmacopeia–
National Formulary.
78
 The FDA enforces any breach of USP standards or 
provisions, as USP does not have its own enforcement component.
79
 
USP also has a voluntary verification program.
80
 It awards a mark to 
ingredients and products that pass its verification requirements and meet 
good manufacturing practices to help ensure the quality of products for 
consumers.
81
 This program could be used as a model to build capacity for 
a verification program for mobile medical apps. 
2. Health on the Net 
In 1995, leaders in telemedicine came together to address growing 
concerns regarding the unequal quality of online health information and 
created the Health on the Net Foundation. HON is a non-profit, non-
governmental organization that has been granted consultative status to the 
Economic and Social Council of the United Nations.
82
 HON’s mission “is 
to guide the growing community of healthcare consumers and providers 
on the World Wide Web to sound, reliable medical information and 
expertise.”83 
The uncertain quality of medical advice provided on web sites and the 
lack of scientific evidence behind treatment claims concerned the founders 
of HON.
84
 Accordingly, HON created a code of conduct, the HONcode.
85
 
The HONcode was the first of its kind to address health and medical 
 
 
 77. U.S. PHARMACOPEIAL CONVENTION, http://www.usp.org (last visited Apr. 8, 2016); see also 
USP Milestones—A Timeline, U.S. PHARMACOPEIAL CONVENTION, http://www.usp.org/about-usp/our-
history/usp-milestones-timeline (last visited Apr. 8, 2016).  
 78. USP in U.S. Law, U.S. PHARMACOPEIAL CONVENTION, http://www.usp.org/about-usp/legal-
recognition/usp-us-law (last visited Apr. 8, 2016).  
 79. Id.  
 80. Working with U.S. FDA, U.S. PHARMACOPEIAL CONVENTION, http://www.usp.org/about-
usp/legal-recognition/working-us-fda# (last visited Apr. 8, 2016).  
 81. USP Verification Services, U.S. PHARMACOPEIAL CONVENTION, www.usp.org/USPVerified 
(last visited Apr. 8, 2016).  
 82. New NGO Status for HON, HEALTH ON THE NET FOUND., http://www.hon.ch/Global/ 
NGO.html (last visited Apr. 8, 2016).  
 83. Mission & Users, HEALTH ON THE NET FOUND., http://www.hon.ch/Global/HON_ 
mission.html (last visited Apr. 8, 2016).  
 84. Quality Issue on the Web and HON, HEALTH ON THE NET FOUND., http://www.hon.ch/ 
MediaCorner/FAQs_HONcode.html (last visited Apr. 8, 2016).  
 85. Id.  
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websites.
86
 HONcode is a self-regulatory, voluntary certification system.
87
 
At the request of a healthcare website, the HONcode team “addresses, 
among other things, the authority of the information provided, data 
confidentiality and privacy, proper attribution of sources, transparency of 
financial sponsorship and the importance of clearly separating advertising 
from editorial content.”88 The HONcode has been adopted by over 3000 
websites.
89
 The foundation is able to operate with a small staff. It depends, 
however, on its Advisory Board and Council and people from around the 
world in the healthcare industry to attain its goals and objectives.
90
 HON is 
inspected by independent organizations to ensure objectivity and 
accuracy.
91
  
Although HON does not have any regulatory or enforcement power, its 
guidelines may be used by governmental regulatory agencies. For 
example, the French government has mandated that all health websites 
must be certified by HON.
92
 This is similar to the way USP regulations 
have been adapted by the FDA to become mandatory and enforceable 
regulations in the United States. 
Private organizations work well for niche or technical issues, because 
larger, more broadly mandated government agencies may lack the time, 
capacity, and expertise to deal with narrow but complex issues. The 
remainder of this Note explores how mobile medical apps continue to 
operate in and adapt to the current regulatory environment, including 
 
 
 86. New NGO Status for HON, supra note 82; see also The HON Code of Conduct for Medical 
and Health Web Sites (HONcode), HEALTH ON THE NET FOUND., http://www.hon.ch/ 
HONcode/Conduct.html (last visited Apr. 8, 2016). The principles of the HONcode are: 
1. Authority—information and advice given only by medical professionals with credentials 
of author/s, or a clear statement if this is not the case; 
2. Complementarity—information and help are to support, not replace, patient-healthcare 
professional relationships which is the desired means of contact; 
3. Confidentiality—how the site treats personal and non-personal information of readers; 
4. Attribution—references to source of information (URL if available) and when it was last 
updated; 
5. Justifiability—any treatment, product or service must be supported by balanced, well-
referenced scientific information; 
6. Transparency of authorship—contact information, preferably including email addresses, 
of authors should be available; 
7. Transparency of sponsorship—sources of funding for the site; 
8. Honesty in advertising and editorial policy—details about advertising on the site and 
clear distinction between advertised and editorial material. 
The HON Code of Conduct for Medical and Health Web Sites (HONcode), supra. 
 87. Quality Issue on the Web and HON, supra note 84. 
 88. Id. 
 89. New NGO Status for HON, supra note 82. 
 90. Questions About the Health on the Net Foundation, HEALTH ON THE NET FOUND., 
http://www.hon.ch/MediaCorner/FAQs_HON.html#HON3 (last visited Apr. 8, 2016).  
 91. Press Release, Health on the Net Found., HON Quality Management System (Oct. 2007).  
 92. Id.  
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possible ways to make the process more efficient than the FDA’s current 
method of regulation.  
II. ANALYSIS 
Although several technology companies have tried to enter into the 
mobile medical app and health data market, including Samsung, Google, 
Verizon, and Qualcomm, Apple’s marketing and branding gurus may give 
mobile medical apps and mobile health data collection the final push 
towards mainstream use.
93
 Regulators must act appropriately and swiftly 
to decide how to handle and regulate the new technology, including the 
health data components of mobile medical applications. 
A. Areas of Potential Public Concern  
Reliability and accuracy are two of the main components of mobile 
medical apps that concern consumers, healthcare providers, and 
government regulators the most. Technology apps do not always specify 
their target audience, such as if the app is specifically intended for 
healthcare professionals or for the general public. This means that 
consumers can access and utilize apps that may be better suited for use by 
a physician.
94
 A physician using a mobile medical app may receive more 
reliable results than the average user, who may not accurately input or 
understand medical data. Inaccurate or unreliable readings from an app 
may lead to undue worry by a user, or may provide a false sense of 
healthiness. 
Reliability is important because doctors and consumers need to know 
which apps are safe for medical purposes and which apps are just for fun 
or gimmicks. A study revealed inconsistencies from one app to another, 
with varying degrees of reliability.
95
 Reliable apps will give consistent, 
accurate results. Accountability will also have to be taken into account 
when considering the reliability of an app, since app developers are quick 
 
 
 93. See Darius Tahir, Why Are Hospitals Using Apple’s HealthKit? It’s Simple, MOD. 
HEALTHCARE (Feb. 5, 2015), http://www.modernhealthcare.com/article/20150205/NEWS/302059938? 
utm_source=twitterfeed&utm_medium=linkedin+company+page. Apple is already beginning to 
dominate the technology market in top hospitals. See, e.g., Christina Farr, Exclusive: Apple’s Health 
Tech Takes Early Lead Among Top Hospitals, REUTERS (Feb. 5, 2015, 5:10 PM), 
http://www.reuters.com/article/2015/02/05/us-apple-hospitals-exclusive-idUSKBN0L90G920150205. 
 94. Cortez, supra note 12, at 1777. Notably, only 28% of physicians who use smartphones and 
18% of physicians who use tablets are “very satisfied” with the quality of apps for their profession. 
Thomas Stringham, Survey of Physicians Suggests Tablets More Useful Than Smartphones, AM. EHR 
(June 12, 2013), http://www.americanehr.com/about/learn_more/news/13-06-12/Survey-of-Physicians-
Suggests-Tablets-More-Useful-Than-Smartphones.aspx. 
 95. Faye Haffey et al., A Comparison of the Reliability of Smartphone Apps for Opioid 
Conversion, 36 DRUG SAFETY 111 (2013). 
https://openscholarship.wustl.edu/law_lawreview/vol93/iss5/8
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to find ways to distance themselves from any results reached by their apps 
through legal disclaimers. Similarly, healthcare providers may be 
unwilling to take on liability for patient action taken as a result of 
information provided by an app. In that situation, a healthcare provider 
would likely argue that patients are not actively involved in treatment with 
the healthcare institution through an app, even if the data may be accessed 
by the healthcare provider.  
Reliability is not always an easy metric to collect, but accuracy is 
something that can be more easily calculated through a non-profit peer 
review verification program. A verification of reliability is necessary 
because some apps offer patients a diagnosis and suggest a course of 
treatment before they even see a physician. In situations like this, accuracy 
is paramount. The reading on the app may lead to self-diagnosis and a 
false sense of security for users. The user may even resist other courses of 
treatment suggested by a treating physician that knows the patient’s 
history and conducted an in-person examination. For example, a risk 
stratification app was created by the American College of Cardiology and 
the American Heart Association to help providers estimate ten-year and 
lifetime risks for atherosclerotic cardiovascular disease (“ASCVD”).96 
Although this app was crafted with physicians in mind, it is freely 
available on iTunes and also includes resources for patients.
97
  
Although the ASCVD Risk Estimator is not a medical device, it offers 
a prognosis and course of action based on personalized health metrics 
gathered by and recorded in the app. The FDA will not be able to regulate 
an app like this, because they do not have regulatory authority, as the app 
will not likely qualify as a device. Instead, the FDA may find that the app 
markets diagnostic capabilities and want to regulate it for safety and 
accuracy. The FDA will find it difficult to do so, as they lack the legal 
authority and technical know-how to correctly assess the safety and 
accuracy of the app. For these reasons, a peer reviewer or organization is 
better suited than the FDA to assess usability and offer usage guidelines 
for consumers. This approach will better ensure accuracy and provide 
proper precautions for consumers. 
B. Expansion of Mobile Health Technology  
Technology companies are beginning to work in coordination with 
healthcare organizations to create apps that are useful for consumers and 
healthcare providers. For example, in a deviation from its consumer-based 
 
 
 96. American College of Cardiology, ASCVD Risk Estimator, ITUNES, https://itunes.apple.com/ 
us/app/ascvd-risk-estimator/id808875968?mt=8 (last visited Apr. 8, 2016). 
 97. Id. 
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sales model, Apple partnered with the Mayo Clinic and electronic health 
records vendor Epic Systems to ensure that the Health app and HealthKit 
properly connect with organizational electronic health records, allowing 
institutions to quickly intervene with patients whose Health app readings 
deviate from the normal range.
98
  
The Mayo Clinic and the Cleveland Clinic are actively exploring ways 
to use the data collected through mobile medical apps to treat patients with 
chronic medical conditions, including high blood pressure and diabetes.
99
 
The Mayo Clinic is testing a service to monitor patient information from 
apps and devices in order to follow up with treatment recommendations.
100
  
Apple engaged with Mount Sinai, the Cleveland Clinic, Johns Hopkins, 
and electronic health records provider Allscripts to discuss how Apple’s 
Health app service will work with those healthcare providers.
101
 Due to the 
Health Information Technology for Economic and Clinical Health Act 
(“Hitech Act”), many healthcare organizations and institutions are 
prepared to integrate additional technology into their systems, such as 
mobile access for patients and providers.
102
 The Hitech Act, part of the 
2009 stimulus package, directed healthcare providers to start using 
electronic health records.
103
 Due to the increased sharing of personal 
health information, privacy will be a key area of concern going forward 
for app developers and healthcare providers, systems, and institutions.
104
  
Partnering with hospitals and health systems is both helpful and 
problematic. On the one hand, apps that are created with the help of 
hospitals, doctors, and other medical personnel could mean improved 
reliability and functionality. On the other, marketing the apps will be 
complicated because hospitals benefit financially from patients coming 
into the hospital, and doctors may feel as though they are losing some 
control over patient care. 
 
 
 98. Neil Versel, Apple’s HealthKit Connects with Mayo and Epic, But Don’t Call It 
Revolutionary, FORBES (June 3, 2014, 1:28 PM), http://www.forbes.com/sites/neilversel/2014/06/03/ 
apples-healthkit-connects-with-mayo-and-epic-but-dont-call-it-revolutionary/.  
 99. Goode, supra note 2.  
 100. Apple Prepares Healthkit Rollout Amid Tangled Regulatory Web, CNBC (Aug. 12, 2014, 
8:44 AM), http://www.cnbc.com/id/101913396#. 
 101. Allscripts will likely make a move quickly, as “[d]ozens of major health systems that use 
Epic’s software will soon be able to integrate health and fitness data from the Health app into Epic’s 
personal health record, called MyChart, according to a person briefed by Apple.” Id. 
 102. Aaron E. Carroll, The Trouble with Apple’s Health App, N.Y. TIMES (June 16, 2014), 
http://www.nytimes.com/2014/06/17/upshot/apples-healthkit-probably-wont-bring-a-new-age.html?_ 
r=0. 
 103. Id. 
 104. Cyber security will be of particular concern after the massive personal information breach at 
Anthem Blue Cross Blue Shield. Reed Abelson & Matthew Goldstein, Anthem Hacking Points to 
Security Vulnerability of Health Care Industry, N.Y. TIMES (Feb. 5, 2015), http://www.nytimes.com/ 
2015/02/06/business/experts-suspect-lax-security-left-anthem-vulnerable-to-hackers.html. 
https://openscholarship.wustl.edu/law_lawreview/vol93/iss5/8
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C. FDA Concerns  
Privacy issues are one reason that a governmental agency may need to 
regulate an app. Many mobile health apps require users to enter private 
personal and health information.
105
 Accordingly, the privacy components 
of medical apps are an area of concern for the FDA and other 
governmental agencies, such as the Department of Health and Human 
Services (“HHS”).106 HHS is working on ascertaining the effects of the 
Health Insurance Portability and Accountability Act (“HIPAA”), which is 
primarily used to shield and control the sharing of protected health 
information on medical apps.
107
 For example, Apple set up its Health app 
so that providers, not Apple, are responsible for following privacy 
requirements.
108
 This is a strategy other application developers could use 
to skirt existing federal regulations, at least as they relate to privacy 
concerns and HIPAA guidelines. If the FDA does regulate mobile medical 
apps, developers will likely search for loopholes and adjust their 
applications to dodge regulation.  
In addition to concerns such as privacy, the FDA often decides whether 
they will regulate a mobile medical health app by evaluating how the app 
is marketed and held out to the public.
109
 For example, in the meeting 
between the FDA and Apple, the FDA said that the agency will choose 
whether to regulate based on the intended use of a device.
110
 During the 
meeting, the FDA addressed Apple’s glucometer example: “[T]he 
glucometer may be unregulated if the intent is for a user to follow their 
blood sugar for the purposes of better nutrition. If the glucometer is 
marketed for diabetics, however, it would more likely be regulated as a 
medical device.”111  
 
 
 105. Fact Sheet 39: Mobile Health and Fitness Apps: What Are the Privacy Risks?, PRIVACY 
RIGHTS CLEARINGHOUSE, https://www.privacyrights.org/mobile-health-and-fitness-apps-what-are-
privacy-risks (last visited Apr. 8, 2016). 
 106. Anne Marie Helm & Daniel Georgatos, Privacy and mHealth: How Mobile Health “Apps” 
Fit into a Privacy Framework Not Limited to HIPAA, 64 SYRACUSE L. REV. 131 (2014).  
 107. “HIPAA protects personally-identifiable health information . . . stored or transmitted by a 
‘covered entity,’ like a care provider or health plan. Patient-generated information from a mobile app, 
for instance, has to be protected once the data is given to a covered entity or its agent.” Apple Prepares 
Healthkit Rollout Amid Tangled Regulatory Web, supra note 100. 
 108. Id. When the iPhone is locked with a passcode, all health and fitness data in the Health app is 
encrypted, and Apps that access HealthKit are required to have a privacy policy. Health, APPLE INC., 
http://www.apple.com/ios/health/ (last visited Apr. 8, 2016). 
 109. Serhat Kurt, Apple and the FDA Have Discussed FDA Regulations Regarding Possible New 
Mobile Products, Sensors and a Glucometer, APPLE TOOLBOX (June 9, 2014), http://appletoolbox. 
com/2014/06/apple-fda-discussed-fda-regulations-regarding-possible-new-mobile-products-sensors-
glucometer/. 
 110. Id. 
 111. Id. 
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Additionally, many app developers have started to include disclaimers 
such as “not intended for use as a medical device,” hidden in the fine print, 
to avoid legal and regulatory liability.
112
 It is unclear how phrases like that 
will protect app developers if the FDA determines the app is marketed as a 
medical tool that will aid in a user’s diagnosis or treatment.  
D. The FDA’s Regulatory Approach  
Health technology experts and scholars have argued for greater FDA 
involvement and regulation in the mobile medical health industry.
113
 
However, the FDA claims to have developed the Agency’s mobile medical 
apps policy to protect public health and promote innovation and does not 
plan on becoming more involved.
114
  
The concern of industry experts and insiders surrounding FDA 
regulation of mobile medical apps is understandable because the FDA has 
not always been the most responsive to changes in medical technology. 
For instance, the FDA was less than responsive when medical devices 
software emerged in the 1980s.
115
 This raised concerns as to why the US 
public should trust the FDA to properly handle the regulation of medical 
health apps.
116
 The extremely fast pace of app development and the 
tendency for an app to become obsolete within a matter of months has 
already been a unique challenge to the FDA.
117
 Bakul Patel, a senior 
 
 
 112. Siemens AG, UA Guide, ITUNES, https://itunes.apple.com/us/app/ua-guide/id918506363?m 
t=8 (last visited Apr. 8, 2016). For instance, the UA Guide app, which is designed for healthcare 
professionals when conducting urinalysis, includes the follow disclaimer:  
The UA Guide is not intended for use as a Medical Device Application, as an accessory to 
regulated medical devices, or for use in clinical practice or to assist in making clinical 
decisions. The UA Guide is intended for educational purposes only and is not commercially 
marketed for a specific medical indication.  
Id. 
 113. See, e.g., Cortez, supra note 12 (arguing for stricter FDA oversight); see also Samuel J. 
Dayton, Rethinking Health App Regulation: The Case for Centralized FDA Voluntary Certification of 
Unregulated Non-Device Mobile Health Apps, 11 IND. HEALTH L. REV. 713 (2014) (suggesting that 
the regulation framework should be created solely by the federal government); Vincent J. Roth, The 
mHealth Conundrum: Smartphones & Mobile Medical Apps—How Much FDA Medical Device 
Regulation Is Required?, 15 N.C. J.L. & TECH. 359 (2014) (exploring the different regulatory 
approaches the FDA could take, and arguing for a more stringent approach). 
 114. Hearing on Mobile Medical Apps, supra note 38. 
 115. Cortez, supra note 12, at 1200–17. 
 116. “We’ve got an agency, which was created long before these technologies even existed, 
proposing to shoehorn health IT into its existing framework . . . . It’s like pushing a square peg into a 
round hole[,]” stated Dan Haley, Athena’s Vice President of Government and Regulatory Affairs. 
Christina Farr, Congress Wants to Kick the FDA Out of Digital Health with This New Bill, 
VENTUREBEAT (Feb. 26, 2014, 8:00 AM), http://venturebeat.com/2014/02/26/new-digital-health-bill-
proposes-to-undermine-the-fda-draws-mixed-reactions/.  
 117. Joshua Barajas, FDA Regulation Can’t Keep Pace with New Mobile Health Apps, PBS (July 
7, 2014), http://www.pbs.org/newshour/rundown/fda-regulation-unable-keep-pace-new-mobile-health-
apps/. 
https://openscholarship.wustl.edu/law_lawreview/vol93/iss5/8
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policy adviser for the FDA’s Center for Devices and Radiological Health, 
discussed this problem, stating that “[t]he whole mobile app world has its 
own ecosystem where things live, die and sort of recycle again, and it’s 
mostly consumer driven.”118 Because of the fast “life cycles” of apps and 
unpredictability of consumer desires, the FDA must either develop a way 
to handle the massive volume and time constraints surrounding medical 
app review, propose a new solution, or yield control to another agency or 
organization. 
For now, the FDA’s focus is on the oversight of mobile medical apps 
intended to supplement a regulated medical device.
119
 For example, an 
application that allows a medical professional to make a diagnosis by 
viewing a medical image such as an ultrasound, MRI, mammogram, or 
PET scan from a picture taken on and transmitted from a smartphone or 
tablet is subject to regulation.
120
 The FDA also intends to focus on medical 
apps that transform a mobile platform into a regulated medical device like 
an ECG.
121
  
Of significant advantage to companies that sell mobile apps, like 
Apple, Google, and Samsung, is that the FDA will not regulate companies 
that sell mobile apps through online marketplaces as manufacturers.
122
 
However, once the FDA finds that an app is a medical device, the app will 
be held to the same stringent standards as any other medical device. The 
gray area encompassing those apps that are neither clearly regulated 
medical devices nor simply apps is problematic for developers, consumers, 
and doctors.  
Regarding the regulation of companies that sell mobile devices that use 
apps, the FDA recently released (under a Freedom of Information Act 
request) a memorandum that described its meeting with Apple executives 
in December of 2013.
123
 Apple was primarily concerned about the FDA’s 
approach to regulation of medical apps, as the release date neared for its 
Health app and Apple Watch.
124
 FDA officials said that the FDA “would 
be more likely to regulate the software that puts [a medical] sensor to use, 
if use of the software alters the device’s use to be a medical device.”125 
The officials also told Apple that “apps that actively measure something” 
 
 
 118. Id. 
 119. The FDA May Want to Regulate Your mHealth App.—Updated, OMNICA CORP., 
http://www.omnica.com/the-fda-will-look-at-your-mhealth-app/ (last visited Apr. 8, 2016). 
 120. Id. 
 121. Id. 
 122. Ki Mae Heussner, Urine-Analysis App Turns to Indiegogo to Help It Win FDA Clearance, 
GIGAOM (July 30, 2013, 4:30 AM), https://gigaom.com/2013/07/30/urine-analysis-app-turns-to-
indiegogo-to-help-it-win-fda-clearance/. 
 123. Kurt, supra note 109. 
 124. The Apple iWatch may include health sensors, such as a glucometer. Id.  
 125. Id. 
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are “diagnostic” and are, therefore, more likely to make the entire tool, a 
mobile phone in this case, subject to regulation.
126
 
Ultimately, the FDA’s guidance leaves it with a substantial amount of 
discretion. This discretion and lack of clarity may result in inconsistent 
FDA action with respect to many health apps, which in turn leads to 
uncertainty for app developers, as the following examples demonstrate. 
E. Instances of FDA Action 
The FDA becomes involved with medical apps when it believes an app 
crosses the line into medical device territory. For instance, in the spring of 
2013, the FDA flagged Biosense’s uChek.127 The app is blocked from the 
market until it receives FDA approval.
128
 A letter from the FDA to 
Biosense stated that the app was blocked because, “though the types of 
urinalysis dipsticks [Biosense] reference[s] for use with [its] application 
are cleared, they are only cleared when interpreted by direct visual 
reading. Since [Biosense’s] app allows a mobile phone to analyze the 
dipsticks, the phone and device as a whole functions as an automated strip 
reader.”129  
Biosense launched a crowdsourcing campaign through Indiegogo to 
help raise money and collect user data for its uChek app to help gain FDA 
clearance.
130
 Biosense will likely need to seek 510(k) approval, which 
does not usually require clinical testing.
131
 The application requires that 
the company prove its device is similar to one already on the market.
132
   
 
 
 126. Scott Gottlieb & Coleen Klasmeier, Why Your Phone Isn’t as Smart as It Could Be, WALL 
ST. J. (Aug. 7, 2014, 8:16 PM), http://www.wsj.com/articles/scott-gottlieb-and-coleen-klasmeier-why-
your-phone-isnt-as-smart-as-it-could-be-1407369163. 
 127. Edney, supra note 16. 
 128. Id. 
 129. Letter from James L. Woods, supra note 55. 
 130. Heussner, supra note 122.  
 131. Premarket Notification 510(k), U.S. FOOD & DRUG ADMIN., http://www.fda.gov/Medical 
Devices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/Premarket
Notification510k/ (last visited Apr. 9, 2016) (“A 510(k) is a premarket submission made to FDA to 
demonstrate that the device to be marketed is at least as safe and effective, that is, substantially 
equivalent, to a legally marketed device (21 CFR 807.92(a)(3)) that is not subject to [Premarket 
Approval].”).  
 132. Edney, supra note 16. 
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F. Instances of FDA Inaction  
The Apple Health app fits into a category of apps that the FDA said it 
will not regulate.
133
 The FDA will not regulate apps that allow “a user to 
collect, log, track and trend data such as blood glucose, blood pressure, 
heart rate, weight or other data from a device to eventually share with a 
heath care provider, or upload it to an online (cloud) database, personal or 
electronic health record,” things the Health app intends to do.134 However, 
just because the FDA declines to regulate an app does not mean a 
developer is safe from other governmental regulation. In 2011, the Federal 
Trade Commission (“FTC”) made its first health claims in the mobile app 
marketplace against two acne apps that purported to be able to treat acne 
with colored lights emitted from smartphones or mobile devices.
135
 The 
FTC alleged that the acne treatment claims made for both apps were 
unsubstantiated.
 
Inaction by the FDA may reveal a willingness on behalf 
of the FDA to not become involved in the free flow of information sent 
directly to healthcare providers from app users. 
G. Ongoing Legislation  
Congressional legislation on mobile medical health apps is currently 
nonexistent.
136
 Congress may take action on the issue of mobile medical 
apps in the future, which will help guide the FDA. The proposed 
legislation includes three acts: The MEDTECH Act,
137
 the SOFTWARE 
Act,
138
 and the PROTECT Act.
139
  
The Medical Electronic Data Technology Enhancement for 
Consumers’ Health Act, or the MEDTECH Act, proposes that electronic 
health records and “other technologies that only store and communicate 
information [be] exempt from FDA regulation.”140 An exemption that 
exists only through FDA guidance and is not law.
141
 This shields apps that 
allow users to store their medical records in an app or communicate health 
 
 
 133. Dolan, supra note 4. 
 134. Examples of Mobile Apps for Which the FDA Will Exercise Enforcement Discretion, supra 
note 44.  
 135. Both claims were settled. Press Release, Fed. Trade Comm’n, “Acne Cure” Mobile App 
Marketers Will Drop Baseless Claims Under FTC Settlements (Sept. 8, 2011).  
 136. “Neither will it be involved in regulating sales or general use of smartphones, tablets, or other 
mobile devices.” HEALTHAFFAIRS & ROBERT WOOD JOHNSON FOUND., supra note 25, at 3. 
 137. MEDTECH Act, S. 1101, 114th Cong. (2015). 
 138. SOFTWARE Act, H.R. 2396, 114th Cong. (2015). 
 139. PROTECT Act of 2014, S. 2007, 113th Cong. (2014). 
 140. John R. Graham, Regulating Mobile Health Apps Under a 38-Year-Old Law: It’s Time for 
Congress to Act, NAT’L CTR. FOR POL’Y ANALYSIS (Dec. 17, 2014), http://healthblog.ncpa.org/ 
regulating-mobile-health-apps-under-a-38-year-old-law-its-time-for-congress-to-act/. 
 141. Id. 
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statistics to their healthcare providers. A new provision of the MEDTECH 
Act gives the FDA the authority to “regulate any medical software 
‘reasonably likely to have serious adverse health consequences.’”142 
However, the new provisions impose limits on the FDA’s power to 
regulate software by requiring the FDA to publish a notice in the Federal 
Register justifying its rationale for regulating the software and allowing 
thirty days for public comment.
143
 The Senate Health, Education, Labor 
and Pensions Committee approved the last version of the MEDTECH Act 
on March 9, 2016.
144
  
The Sensible Oversight for Technology which Advances Regulatory 
Efficiency Act, or the SOFTWARE Act, first introduced in October of 
2013 and re-introduced in January of 2015, “divides health IT into only 
two categories: medical software to be regulated by the U.S. Food and 
Drug Administration and health software that won’t be regulated.”145 If the 
bill passes, the FDA must develop a new regulatory program to regulate 
the first category of medical software.
146
 According to the Act, medical 
software “is intended to analyze patient-specific information and other 
information to recommend to healthcare professionals a single treatment 
or course of action . . . without the need for such professionals to perform 
additional interpretation of, or to independently confirm the means for, 
such recommendation.”147 The language implies the Act will pertain to 
software used by healthcare professionals in healthcare settings, rather 
than technology found in mobile medical apps. Congress has not taken 
further action since the Act was reintroduced in January 2015. 
If passed, the Preventing Regulatory Overreach to Enhance Care 
Technology (“PROTECT”) Act of 2014 would strip authority from the 
regulators who currently oversee health technology, particularly the 
FDA.
148
 The bill is intended to relieve the FDA of regulatory burdens, and 
“its sponsors say the bill would prioritize the FDA’s attention to 
technologies that pose the greatest health risk, rather than giving the 
agency broad authority over ‘low-risk health IT’ and thus hindering 
 
 
 142. David Pittman, MEDTECH Act Revision Boosts FDA’s Power, POLITICO (Mar. 8, 2016, 
10:00 AM), http://www.politico.com/tipsheets/morning-ehealth/2016/03/medtech-act-revision-boosts-
fdas-power-213094#ixzz44sVlgGVd. 
 143. Id. 
 144. Jeannie Baumann, Senate Panel Approves Zika Measure, Other Innovation Bills, 
BLOOMBERG (Mar. 10, 2016), http://www.bna.com/senate-panel-approves-n57982068382/. 
 145. Dan Bowman, SOFTWARE Act Revision ‘Simplifies’ Health IT Regulation, 
FIERCEHEALTHCARE (Jan. 26, 2015, 11:40 AM), http://www.fiercehealthit.com/story/software-act-
revision-simplifies-health-it-regulation/2015-01-26. 
 146. Id. 
 147. Id. (internal quotation marks omitted). 
 148. Farr, supra note 116. 
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innovation.”149 Some believe that this bill goes too far and will put 
consumers at risk if the medical apps do not function as advertised.
150
 As 
with most legislation, it is unclear when and to what extent this legislation 
will pass, but there has not been any action taken since 2014, when it was 
referred to the Committee on Health, Education, Labor and Pensions.
151
  
The current absence of regulation leaves the mobile health industry 
uncertain. Dan Haley, Vice President of Government and Regulatory 
Affairs at Athena, is unsatisfied that the FDA gave the industry little more 
than a set of “non-binding recommendations” that may be changed at the 
FDA’s whim.152 Such uncertainty may discourage innovation in the 
medical app market. Developers have expressed concern that the FDA’s 
unclear guidelines and enforcement policies have scared them away from 
designing more mobile medical apps.
153
 Additionally, classification as a 
medical device could subject medical mobile health apps to the 2.3% 
medical device tax from the Patient Protection and Affordable Care Act 
(“ACA”).154 “Overbroad application of this classification could stall the 
innovation, investment, and job creation that wireless smartphones and 
apps are bringing to healthcare, as well as ultimately impact the larger 
wireless ecosystem.”155  
As Google co-founder Sergey Brin put it during a speech to CEOs of 
technology companies in Silicon Valley, “[h]ealth is just so heavily 
regulated . . . it’s just a painful business to be in.”156 An advantage of 
smartphone apps is that they are constantly improved through updates, 
“yet under the FDA’s existing rules, once a medical app comes under the 
agency’s premarket scheme, each iteration can require formal submissions 
 
 
 149. Eric Wicklund, Opponents Say PROTECT Act Could Destroy mHealth, Endanger Patients, 
MOBIHEALTHNEWS.COM (Feb. 17, 2014), http://www.mhealthnews.com/news/opponents-protect-act-
destroy-mhealth-endanger-patients-mobile-FDA. 
 150. A coalition of patient advocacy organizations, including the American Medical Women’s 
Association, the Jacobs Institute of Women’s Health, National Consumers League, National 
Physicians Alliance, National Research Center for Women & Families, and the National Women’s 
Health Network, voiced such a concern in a letter sent to Senator Tom Harkin (D-Iowa), Chairman of 
the Senate Committee on Health, Education, Labor and Pensions (HELP) on February 14, 2014. Greg 
Slabodkin, Industry Group Voices ‘Extreme’ Concern with PROTECT Act, FIERCEHEALTHCARE (Feb. 
19, 2014, 4:20 PM), http://www.fiercemobilehealthcare.com/story/industry-group-voices-extreme-
concern-protect-act/2014-02-19. 
 151. PROTECT Act of 2014, S. 2007, 113th Cong. (2014). 
 152. Farr, supra note 116.  
 153. Christina Farr, Entrepreneurs Say the FDA is Killing Medical Innovation, VENTUREBEAT 
(Apr. 30, 2013, 7:00 AM), http://venturebeat.com/2013/04/30/stifled-by-regulation-entrepreneurs-
take-life-saving-devices-overseas/.  
 154. “Depending on how the law is interpreted, this tax potentially could apply to mobile health 
applications as well as smartphones and tablets.” Health Information Technologies, supra note 21, at 
2. 
 155. Id.  
 156. Gottlieb & Klasmeier, supra note 126. 
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and in some cases review by the agency before it can be offered to 
consumers,” which is prohibitively costly for developers in terms of time 
and money.
157
 Stringent regulation could slow or halt future development 
and improvements of apps and make developers less likely to create such 
apps in the first place, out of fear of excessive regulation. To allow tech 
companies to develop new and useful apps and encourage innovation in 
this important field, the process must be made less “painful.” 
III. PROPOSAL 
Despite the confusing and changing regulatory climate, technology 
companies continue to explore possibilities in the healthcare industry. 
Government regulators and agencies must either keep up with 
advancements in technology or refrain from the regulation of mobile 
medical apps. The current gray area creates confusion for developers, 
consumers, and the healthcare industry. There are three possibilities for the 
regulation of mobile medical apps: (1) FDA regulation, (2) regulation by 
non-profits that are given standing and enforcement power through 
legislation, or (3) regulation by non-profits without legislative standing or 
governmental oversight.  
A. Government Regulation and Certification  
The first option is government regulation, likely by the FDA. As 
discussed in Part I, if the FDA continues to attempt to regulate mobile 
medical apps, it needs to address challenges like the fast pace of 
development, as the sheer volume of app production could overwhelm the 
FDA’s limited resources. 
As part of a regulatory scheme for mobile medical apps, the FDA may 
find a way to streamline a verification program, similar to CE verification 
in the United Kingdom, that would allow consumers and healthcare 
professionals to know if an app is safe. Copying the UK approach may not 
be popular in the United States because of the strict definition of a medical 
app in the United Kingdom.
158
 Accordingly, the threshold for FDA 
regulation should not be too stringent, as a backlog will quickly form if the 
process is too lengthy, and beneficial mobile medical apps will take too 
long to get to the market. Additionally, the FDA should allow for updates 
and minor changes to be made without requiring new certification to deal 
with the rapidly changing nature of mobile medical apps.  
 
 
 157. Id. 
 158. Guidance on Medical Device Software, supra note 68. 
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A certification system would provide a greater amount of preventative 
care, conforming with one of the ACA’s key initiatives.159 If a certification 
system exists, doctors can give better recommendations regarding which 
apps patients can use to monitor their vital statistics, chronic conditions, 
and minor illnesses. Increased collaboration between app makers, like 
Apple, and electronic health record systems, like Epic and AllScripts, will 
aid and streamline data sharing between apps and healthcare facilities.  
The use of apps for monitoring and preventive care will lower 
healthcare costs for providers and consumers. Apps that are medical 
devices and, therefore, regulated by the FDA, may lower healthcare costs 
because they will provide millions of doctors and patients with easy access 
to medical advice. Unlike a simple online search, mobile medical apps 
have the potential to personalize a diagnosis because apps are interactive 
and able to utilize the features of smartphones to get accurate data and 
health history and trends instantly. Patients no longer have to go into a 
doctor’s office to get an accurate reading and interpretation of their heart 
rate, blood pressure, or blood sugar. Doctors can receive the data through 
the apps and interpret the metrics, monitor, and give advice to their 
patients in lieu of frequent, and costly, face-to-face appointments.  
Rising healthcare costs make mobile medical app solutions more 
attractive to consumers, which increases the importance of making sure 
apps on the market are safe and effective. Additionally, many Americans 
do not seek preventative care because they do not have easy access to 
healthcare providers or do not think it is necessary to go to the doctor for 
preventative care.
160
 If preventative care and monitoring becomes more 
accessible through mobile phone apps, people may be more likely to 
monitor their health and know when to seek care if a problem arises. This 
is especially true when people use mobile health apps that are integrated 
with hospitals and health systems. More efficient and cost effective 
preventative care and monitoring is likely what Apple has in mind as it 
builds relationships with hospitals and corporations like the Mayo Clinic 
and Epic Systems.
161
  
The slow progression of legislation and bureaucracy is one of the key 
reasons that a non-governmental solution may bring more expedient 
 
 
 159. Insurers are required to cover preventative services for children, seniors, women, and adults, 
including blood pressure screenings, cholesterol screenings, mammograms, colonoscopies, and 
osteoporosis screenings. See Coverage to Care, U.S. DEP’T OF HEALTH & HUMAN SERVS., 
http://www.hhs.gov/healthcare/prevention/index.html (last visited Apr. 8, 2016). 
 160. Eryn Brown, Many Didn’t Benefit from Preventive Care Before 2010, CDC Says, L.A. TIMES 
(June 14, 2012), http://articles.latimes.com/2012/jun/14/news/la-heb-cdc-prevention-report-healthcare-
reform-20120614. 
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results. Expediency is fundamental to keep pace with an industry 
developing as rapidly as mobile medical care. 
B. Non-Profit Peer Review with Government Partnership  
The second option is regulation by a non-profit organization comprised 
of experts in the field. This non-profit organization can be given an 
enforcement arm adopted through legislation. Similar to prescription drug 
guidance and standards set forth by the USP, this approach would provide 
a uniform set of guidelines for developers, regulators, and consumers.  
The FDA, like many governmental agencies, is often overburdened and 
underfunded.
162
 Therefore, allowing a private organization with 
specialized expertise in mobile medical health applications to regulate the 
industry may be more efficient and effective.
163
 The public-private 
relationship between the FDA and USP is a perfect example of how a non-
profit organization that specializes in a certain area can help the 
government regulate an important but very complex field. The 
development of guidelines or a certification system for mobile health apps 
by a non-profit and/or peer review may lead to safer apps on the market 
and advance public health initiatives. A set of guidelines or “stamp of 
approval” will allow consumers to make better decisions when choosing 
which mobile medical apps to use for things like preventative care.  
However, this option may take a long period of time to achieve because 
the organization must gain peer and political approval before their 
recommendations would be given serious legislative consideration and be 
given agency recognition status. Creating an organization to provide 
guidance is the first step towards achieving this goal and may provide 
consumers with useful information until formal guidance and regulation is 
published.  
C. Non-Profit Guidance and Certification  
The third option is regulation by a non-profit organization without 
legislative standing, akin to how HON operates. HON was created in 
response to an enormous and growing amount of medical information 
available on the Internet.
164
 The increasing use of smartphones and 
 
 
 162. SUBCOMM. ON SCI. AND TECH., FDA SCIENCE AND MISSION AT RISK: REPORT OF THE 
SUBCOMMITTEE ON SCIENCE AND TECHNOLOGY (2007), available at http://www.fda.gov/ohrms/ 
dockets/ac/07/briefing/2007-4329b_02_01_FDA%20Report%20on%20Science%20and%20Technolog 
y.pdf. 
 163. See Dayton, supra note 113. 
 164. The Services Offered by HON, HEALTH ON THE NET FOUND., http://www.hon.ch/home1.html 
(last visited Apr. 8, 2016).  
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growing availability of medical apps is similar to the rapid growth of 
medical websites that triggered the establishment of HON. Similar 
concerns about mobile medical apps may facilitate the formation of a peer 
organization to assist in the verification of mobile apps for efficacy and 
safety. Ideally, as in a legislatively recognized non-profit, the government 
will eventually adopt regulations proposed by the non-profit organization, 
akin to what some European countries have done for HON certification.  
HON recognized that increasing numbers of the general public sought 
healthcare information online, but oversight of such information—and 
misinformation—was lacking.165 This problem, however, could be 
improved through the certification of many mobile medical apps. A 
voluntary certification process for mobile medical apps could be extremely 
beneficial for lay consumers as well as mobile health app developers and 
health professionals.  
Due to the problems faced by the FDA regarding the regulation of 
mobile medical apps, a non-profit alternative may be more effective.
166
 
This approach will better ensure accuracy and provide proper precautions 
for consumers. It will also have the capability to operate on an expedited 
timeframe.  
A system similar to Health on the Net would be most conducive for the 
review and certification of mobile health and medical applications that do 
not fall within the purview of FDA guidelines or regulations. Applications 
that do not fall within either category are apps that contain medical 
information but in no way analyze or use patient metrics to create a 
diagnosis or treatment suggestions. Although such apps are not as likely to 
cause harm, a peer review and certification system could provide much 
needed guidance. This will help to reassure consumers that they are using 
an app that provides safe and reliable medical information.  
A non-profit verification program would be completely voluntary for 
app developers and would not have any enforcement powers for non-
compliance. The only exception would be in taking away certification if 
the app developer voluntarily applied for certification and later changed its 
application without seeking further approval. If a government wants the 
guidelines to be enforceable, the legislature may adopt a non-profit’s 
guidelines as law, similar to what France did by enforcing the guidance 
promulgated by Health on the Net.   
 
 
 165. In fact, “[o]ne in ten sites about cancer treatment and mental diseases have wrong 
information.” Quality Issue on the Web and HON, supra note 84. 
 166. See Roth, supra note 113. 
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If a group interested in the safety and efficacy of mobile medical apps 
could find a platform to present its ideas, it could have an accelerated path 
to recognition and credibility. A non-profit organization will have to build 
credibility within academic and medical communities. Health on the Net 
did this by partnering with governments and the United Nations.
167
 
Affiliating with an existing nongovernmental organization or non-profit 
may help an organization build credibility and recognition more 
expediently. Health on the Net came about after a summit regarding the 
rapid spread of information and misinformation on the Internet and 
flourished through its affiliation with the United Nations.
168
 Because of the 
growing number of people in the world with access to smartphones, the 
international community may want to partner with an organization focused 
on the verification of safe and reliable mobile medical apps.  
CONCLUSION 
Part III discussed three potential regulators of health apps: (1) the 
FDA; (2) a non-profit organization that will organize a voluntary 
verification program; or (3) a non-profit organization that will develop 
guidelines that a governmental agency, likely the FDA, will adopt and 
enforce. A peer review system combined with a non-profit organization 
that specializes in mobile medical technology will be more efficient and 
useful for mobile medical apps than the current FDA guidelines (or lack 
thereof). This Note shows that the ideal level of formality is a sensible 
approach to regulation, somewhere in between the verification methods of 
USP and Health on the Net.  
Too much government regulation may decrease investment in mobile 
medical technology because regulation is costly and time consuming. 
Decreased investment will hamper research and development for mobile 
medical apps that could help monitor people’s health and wellbeing. A 
peer review and nonprofit option is less expensive and more efficient. 
However, those options lack regulatory enforcement power. The FDA can 
eventually adopt some of the private guidelines once they have proven to 
be effective and beneficial. Current FDA guidance may be preventing 
useful apps from coming onto the market, while allowing mere gimmicks 
to enter and remain on the health app market. Developers of useful apps 
are wary of becoming entangled in a complex and vague regulatory web 
and the costs associated with it. The case-by-case review being utilized by 
the FDA is not an effective way of keeping up with the growing volume 
 
 
 167. New NGO Status for HON, supra note 82.  
 168. Id.  
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and demand for mobile medical apps. By giving app developers a quicker 
and cheaper alternative route to getting safe, reliable, and accurate mobile 
medical health apps to consumers, the mobile health field will continue to 
grow and produce high quality medical apps. 
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